Literature DB >> 8092997

Role of glycosylation in transport and enzymic activity of neutral endopeptidase-24.11.

M H Lafrance1, C Vézina, Q Wang, G Boileau, P Crine, G Lemay.   

Abstract

Neutral endopeptidase (NEP, EC 3.4.24.11) is a major ectoenzyme of the brush-border membrane. The ectodomain of NEP contains five putative N-glycosylation sites. In order to determine the role of the addition of sugar moieties on the activity and intracellular transport of NEP, we have used site-directed mutagenesis to remove all or some of the five potential sites of sugar addition in membrane-bound and secreted forms of the enzyme. Expression of NEP glycosylation mutants in COS-1 cells showed that all five sites are used for sugar addition. Immunoblotting of NEP in COS-1 cell extracts or culture media indicated that total expression of normal membrane-bound NEP was not affected by mutations at glycosylation sites, whereas this expression level appeared to be strictly dependent on the number of glycosylation sites retained on the soluble form. The transport to the cell surface was also reduced by decreased glycosylation, but again the phenomenon appeared more drastic in the case of the soluble form than for the membrane-bound enzyme. Enzyme activity was decreased by deglycosylation. However, the presence of either of two crucial sites (sites 1 and 5; numbered from the N-terminus of the protein) was sufficient to recover close-to-normal enzymic activities. Transport to the cell surface and enzyme activity of NEP are thus both dependent on sugar residues, probably through different conformational constraints. These constraints seem to be local for enzyme activity but more global for transport to the cell surface.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8092997      PMCID: PMC1137249          DOI: 10.1042/bj3020451

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein.

Authors:  M A Shipp; N E Richardson; P H Sayre; N R Brown; E L Masteller; L K Clayton; J Ritz; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

2.  Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase).

Authors:  B Malfroy; W J Kuang; P H Seeburg; A J Mason; P R Schofield
Journal:  FEBS Lett       Date:  1988-02-29       Impact factor: 4.124

Review 3.  Transport of secretory and membrane glycoproteins from the rough endoplasmic reticulum to the Golgi. A rate-limiting step in protein maturation and secretion.

Authors:  H F Lodish
Journal:  J Biol Chem       Date:  1988-02-15       Impact factor: 5.157

4.  Glycosylation at specific sites of erythropoietin is essential for biosynthesis, secretion, and biological function.

Authors:  S Dubé; J W Fisher; J S Powell
Journal:  J Biol Chem       Date:  1988-11-25       Impact factor: 5.157

5.  Exploration of the catalytic site of endopeptidase 24.11 by site-directed mutagenesis. Histidine residues 583 and 587 are essential for catalysis.

Authors:  A Devault; V Sales; C Nault; A Beaumont; B Roques; P Crine; G Boileau
Journal:  FEBS Lett       Date:  1988-04-11       Impact factor: 4.124

6.  Vesicular stomatitis virus G proteins with altered glycosylation sites display temperature-sensitive intracellular transport and are subject to aberrant intermolecular disulfide bonding.

Authors:  C E Machamer; J K Rose
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

7.  Expression of neutral endopeptidase (enkephalinase) in heterologous COS-1 cells. Characterization of the recombinant enzyme and evidence for a glutamic acid residue at the active site.

Authors:  A Devault; C Nault; M Zollinger; M C Fournie-Zaluski; B P Roques; P Crine; G Boileau
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

8.  Cell surface expression of glycosylated, nonglycosylated, and truncated forms of a cytoplasmic protein pyruvate kinase.

Authors:  S W Hiebert; R A Lamb
Journal:  J Cell Biol       Date:  1988-09       Impact factor: 10.539

9.  The role of the asparagine-linked oligosaccharides of the alpha subunit in the secretion and assembly of human chorionic gonadotrophin.

Authors:  M M Matzuk; I Boime
Journal:  J Cell Biol       Date:  1988-04       Impact factor: 10.539

10.  Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase.

Authors:  M Letarte; S Vera; R Tran; J B Addis; R J Onizuka; E J Quackenbush; C V Jongeneel; R R McInnes
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

View more
  8 in total

1.  Molecular cloning and biochemical characterization of a new mouse testis soluble-zinc-metallopeptidase of the neprilysin family.

Authors:  G Ghaddar; A F Ruchon; M Carpentier; M Marcinkiewicz; N G Seidah; P Crine; L Desgroseillers; G Boileau
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

2.  Cell-specific activity of neprilysin 2 isoforms and enzymic specificity compared with neprilysin.

Authors:  Christiane Rose; Stéphanie Voisin; Claude Gros; Jean-Charles Schwartz; Tanja Ouimet
Journal:  Biochem J       Date:  2002-05-01       Impact factor: 3.857

3.  Casein kinase 2 dependent phosphorylation of neprilysin regulates receptor tyrosine kinase signaling to Akt.

Authors:  Martin Siepmann; Sathish Kumar; Günter Mayer; Jochen Walter
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

4.  beta-Amyloid degradation and Alzheimer's disease.

Authors:  Deng-Shun Wang; Dennis W Dickson; James S Malter
Journal:  J Biomed Biotechnol       Date:  2006

Review 5.  Metabolism of amyloid β peptide and pathogenesis of Alzheimer's disease.

Authors:  Takaomi C Saido
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

Review 6.  Early Stage Glycosylation Biomarkers in Alzheimer's Disease.

Authors:  Patricia Regan; Paula L McClean; Thomas Smyth; Margaret Doherty
Journal:  Medicines (Basel)       Date:  2019-09-03

Review 7.  Neprilysin expression and functions in development, ageing and disease.

Authors:  N N Nalivaeva; I A Zhuravin; A J Turner
Journal:  Mech Ageing Dev       Date:  2020-09-26       Impact factor: 5.432

8.  Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.

Authors:  Matthew L Hemming; Michaela Patterson; Casper Reske-Nielsen; Ling Lin; Ole Isacson; Dennis J Selkoe
Journal:  PLoS Med       Date:  2007-08       Impact factor: 11.069

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.